3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
48
Prostatic Neoplasms, Castration-Resistant
3
Adenocarcinoma
3
Urogenital Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Diseases
2
Non-metastatic Castration-resistant Prostate Cancer
2
Neoplasms
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Male Urogenital Diseases
2
Bulbo-Spinal Atrophy, X-Linked
2
Biochemically Recurrent Prostate Cancer
2
Urogenital Diseases
1
Triple Negative Breast Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Refractory or Relapsed Solid Tumors
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
High-Risk Localized Prostate Cancer
1
Granulosa cell tumor of the ovary
1
Genital Diseases, Male
1
Fatigue
1
Depression
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
Azacitidine
25
venetoclax
19
Cyclophosphamide
17
fludarabine phosphate
14
Whole-Body Irradiation
13
Biopsy
13
fludarabine
12
Specimen Handling
12
Tacrolimus
11
Mycophenolic Acid
11
Decitabine
10
Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
9
Injections
8
Cytarabine
8
Busulfan
8
decitabine and cedazuridine drug combination
7
Melphalan
7
X-Rays
5
Hematopoietic Stem Cell Transplantation
5
Cyclosporine
5
Sirolimus
4
ruxolitinib
3
olutasidenib
3
enasidenib
3
cedazuridine
3
Magnetic Resonance Spectroscopy
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
darolutamide
×
1 year
×
Clear all
No trials found.